| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 01/12/1995 | CA2531868A1 Process for the preparation of thalidomide |
| 01/12/1995 | CA2166462A1 Double-stranded peptide nucleic acids |
| 01/12/1995 | CA2166461A1 Higher order structure and binding of peptide nucleic acids |
| 01/12/1995 | CA2166413A1 Anti-atherosclerotic diaryl compounds |
| 01/12/1995 | CA2166298A1 Peptide family, designated as xenonins |
| 01/12/1995 | CA2166278A1 A truncated keratinocyte growth factor (kgf) having increased biological activity |
| 01/12/1995 | CA2165792A1 Tetrazole derivatives |
| 01/12/1995 | CA2142472A1 Arylidene and heteroarylidene oxindole derivatives and process for their preparation |
| 01/11/1995 | EP0633261A1 Quinoline-3-acetic acid derivative, process for producing the same, and use thereof |
| 01/11/1995 | EP0633260A1 2,3-Dihydro-1,4-benzodioxin-5-yl-piperazine derivatives having 5-HT1A-antagonistic activity |
| 01/11/1995 | EP0633029A2 Further improvements relating to drug delivery systems |
| 01/11/1995 | EP0633022A2 Chondroprotective flavones |
| 01/11/1995 | EP0633021A1 Chondroprotective agents |
| 01/11/1995 | EP0632829A1 Thrombin receptor antagonists |
| 01/11/1995 | EP0632726A1 A method for treating kaposi's sarcoma and blocking or inhibiting vascular permeability |
| 01/11/1995 | EP0632723A1 Use of transglutaminase inhibitor for the treatment of scar tissue |
| 01/11/1995 | EP0544821B1 Indole derivatives as antiallergy and antiinflammatory agents |
| 01/11/1995 | EP0324745B1 Topical agents containing prostacycline derivatives |
| 01/11/1995 | CN1027370C Process for production of thiazole derivatives |
| 01/11/1995 | CN1027368C Process for preparing substituted quinoline derivatives |
| 01/11/1995 | CN1027346C Wound healing and bone regeneration composition |
| 01/10/1995 | US5380866 Alkyl substituted nitroimidazole acetic acids |
| 01/10/1995 | US5380858 Process for the preparation of intermediates useful for the synthesis of histamine receptor antagonists |
| 01/10/1995 | US5380837 Alpha-methyldopa or its salt with D-glucose residues attached in alpha fashion to either or both hydroxyls; pharmaceutical compositions |
| 01/10/1995 | US5380760 Polyisobutylene adhesive |
| 01/10/1995 | US5380738 2-substituted oxazoles further substituted by 4-fluorophenyl and 4-methylsulfonylphenyl as antiinflammatory agents |
| 01/10/1995 | US5380736 Cholecystokinin and gastric antagonist |
| 01/10/1995 | US5380727 Synergistic combination for treating herpes infections |
| 01/10/1995 | US5380713 Serine protease inhibitors |
| 01/10/1995 | US5380712 Truncated human serum albumin polypeptides as plasma expanding agents |
| 01/10/1995 | CA2126513A1 Chondroprotective agents |
| 01/10/1995 | CA2126512A1 Chondroprotective agents |
| 01/10/1995 | CA1333852C Moulding contact lenses |
| 01/05/1995 | WO1995000850A1 A novel family of pollen proteinases, methods of use thereof and compositions derived therefrom |
| 01/05/1995 | WO1995000643A2 Human cell adhesion protein aamp-1 and uses thereof |
| 01/05/1995 | WO1995000642A1 Vertebrate apoptosis gene: compositions and methods |
| 01/05/1995 | WO1995000531A1 NOVEL PROCESS FOR PREPARING 17β-SUBSTITUTED 4-AZAANDROSTANE DERIVATIVES |
| 01/05/1995 | WO1995000520A1 Indolocarbazole compound useful as proteinkinase c inhibitor |
| 01/05/1995 | WO1995000517A1 Process for producing imidazole derivative |
| 01/05/1995 | WO1995000516A1 Novel chemical compounds having pde-iv inhibition activity |
| 01/05/1995 | WO1995000514A1 Novel carbocyclic nucleoside agents useful as selective inhibitors of proinflammatory cytokines |
| 01/05/1995 | WO1995000508A1 Phenyrrole derivatives and their use as dopamine d3 antagonists |
| 01/05/1995 | WO1995000505A1 Aminoacid derivatives as no synthase inhibitors |
| 01/05/1995 | WO1995000501A2 Phenyl heterocycles as cyclooxygenase-2 inhibitors |
| 01/05/1995 | WO1995000497A1 Inhibitors of farnesyl-protein transferase |
| 01/05/1995 | WO1995000494A1 Novel method for preparing ergothioneine |
| 01/05/1995 | WO1995000480A1 Novel intermediates for the preparation of antihistaminic 4-diphenylmethyl/diphenylmethoxy piperidine derivatives |
| 01/05/1995 | WO1995000472A1 1,2 diacylated hydrazine derivatives and their use as all adhesion inhibitors |
| 01/05/1995 | WO1995000176A1 Compositions for treating hypoxia-associated ocular complications |
| 01/05/1995 | WO1995000161A1 Neuropeptide y antagonists and agonists |
| 01/05/1995 | WO1995000160A1 Programmed cell death genes and proteins |
| 01/05/1995 | WO1995000147A1 4-AZA-PREGNANE 5α-REDUCTASE ISOZYME 1 INHIBITORS |
| 01/05/1995 | WO1995000139A1 Compounds |
| 01/05/1995 | WO1995000136A1 Method for treating hyperkeratosis and diseases mediated by proteases |
| 01/05/1995 | WO1994017099A3 BIOLOGICALLY ACTIVE TGF-β1 AND TGF-β2 PEPTIDES |
| 01/05/1995 | CA2364039A1 Use of phenyl heterocycles in the relief or treatment of rheumatoid arthritis, osteoarthritis, fever, pain, headache or dysmenorrhea |
| 01/05/1995 | CA2165777A1 Programmed cell death genes and proteins |
| 01/05/1995 | CA2165559A1 Human cell adhesion protein aamp-1 and uses thereof |
| 01/05/1995 | CA2165200A1 Neuropeptide y antagonists and agonists |
| 01/05/1995 | CA2165176A1 Inhibitors of farnesyl-protein transferase |
| 01/05/1995 | CA2165077A1 4-aza-pregnane 5.alpha.-reductase isozyme 1 inhibitors |
| 01/05/1995 | CA2164955A1 Method for treating hyperkeratosis and diseases mediated by proteases |
| 01/05/1995 | CA2163888A1 Phenyl heterocycles as cyclooxygenase-2 inhibitors |
| 01/04/1995 | EP0632051A1 Anti-picornaviral agents |
| 01/04/1995 | EP0632036A2 Amide and urea derivatives having anti-hypercholesteremic activity, their preparation and their therapeutic uses |
| 01/04/1995 | EP0632033A1 Novel benzopyran derivative |
| 01/04/1995 | EP0632016A1 1,2-Diacylated hydrazine derivatives and their use as cell adhesion inhibitors |
| 01/04/1995 | EP0632008A1 Pentanoic acid derivatives |
| 01/04/1995 | EP0631784A1 Sulphated polysaccharides having anti-inflammatory activity |
| 01/04/1995 | EP0631776A1 Use of beta-naphthoquinone for accelerating the proliferation of endothelial cells and inhibiting no synthases |
| 01/04/1995 | EP0631727A1 Lipase inhibitor derived from a defatted rice germ |
| 01/04/1995 | EP0631619A1 Reconstituted cartilage tissue |
| 01/04/1995 | EP0561941B1 N-substituted lactams useful as cholecystokinin antagonists |
| 01/04/1995 | EP0435946B1 Methods for modifying the binding of cell adhesion receptors |
| 01/04/1995 | CN1096954A Anti-senility medicine made of compound amino-acids and trace elements |
| 01/04/1995 | CN1027271C Method for preparation of polypeptide with nor-state and nor-cyclostatine |
| 01/03/1995 | US5378825 Backbone modified oligonucleotide analogs |
| 01/03/1995 | US5378725 Administering as antitumor or anticarcinogenic agent to mammals |
| 01/03/1995 | US5378723 Cholinergic agonist and blocking agents |
| 01/03/1995 | US5378721 Aromatase inhibitors |
| 01/03/1995 | US5378720 Treatment of rheumatoid arthritis, emphysema, pancreatitis |
| 01/03/1995 | US5378716 Pyrazol-1-yl phenoxyacetic acid compounds which have useful pharmaceutical utility |
| 01/03/1995 | US5378710 17β-substituted aza-androstane derivatives |
| 01/03/1995 | US5378699 Treatment of immune diseases, cell proliferation, restenosis and smooth muscle cells |
| 01/03/1995 | US5378469 Dehydration |
| 01/03/1995 | CA1333803C .alpha.-substituted 4-(quinolin-2-yl-methoxy)phenylacetic acids and esters |
| 01/03/1995 | CA1333802C Substituted 4-(quinolin-2-yl-methoxy)phenyl-acetic acid derivatives |
| 01/02/1995 | CA2127230A1 Methods and reagents for inhibiting cholesterol absorption in humans mediated by pancreatic cholesterol esterase |
| 01/02/1995 | CA2127187A1 Anti-picornaviral agents |
| 12/31/1994 | CA2126994A1 Amide and urea derivatives having anti-hypercholesteremic activity, their preparation and their therapeutic uses |
| 12/28/1994 | EP0630887A1 4-(aryl-substituted)-piperidines as neurokinin receptor antagonists |
| 12/28/1994 | EP0630649A1 Combination of an inhibitor of inducible nitric oxide synthase (iNOS) and an antiinflammatory agent, e.g. a corticosteroid |
| 12/28/1994 | EP0630644A1 Anti-microbial and interferon-inducing pharmaceutical compound |
| 12/28/1994 | EP0630409A1 Defective packaging non-oncoviral vectors based on mpmv and hiv |
| 12/28/1994 | EP0630405A1 Novel V28 seven transmembrane receptor |
| 12/28/1994 | EP0630379A1 Cyclic ketal derivatives |
| 12/28/1994 | EP0630378A1 Cyclic ketal derivatives |
| 12/28/1994 | EP0630248A1 Use if estriol for treating climacteric osteoporosis |
| 12/28/1994 | EP0630245A1 Protein kinase c inhibitor |
| 12/28/1994 | EP0630244A1 Muscarinic agonists |